TGFB1 and neoplasm: TGF-β1-neutralizing Ab strongly abrogated NKG2D downmodulation, and TDE-derived TGF-β1 decreased the expression of NKG2D, which weakened the ability of CD8+ and γδ+ T cells to recognize tumor-associated antigens (TAAs) [142].